<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Surg</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Surg</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Surgery</journal-title></journal-title-group><issn pub-type="ppub">2168-6254</issn><issn pub-type="epub">2168-6262</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10077134</article-id><article-id pub-id-type="pmcid-ver">PMC10077134.1</article-id><article-id pub-id-type="pmcaid">10077134</article-id><article-id pub-id-type="pmcaiid">10077134</article-id><article-id pub-id-type="pmid">37017945</article-id><article-id pub-id-type="doi">10.1001/jamasurg.2023.0276</article-id><article-id pub-id-type="publisher-id">soi230009</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group></article-categories><title-group><article-title>Long-term Outcomes Following a Comprehensive Quality Assurance and Process Improvement Endeavor to Minimize Opioid Use After Kidney Transplant</article-title><alt-title alt-title-type="headline">Long-term Outcomes of Opioid-Sparing Protocol After Kidney Transplant</alt-title><alt-title alt-title-type="running-head">Long-term Outcomes of Opioid-Sparing Protocol After Kidney Transplant</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Carcella</surname><given-names initials="T">Taylor</given-names></name><degrees>PharmD</degrees><xref rid="soi230009aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Patel</surname><given-names initials="N">Neha</given-names></name><degrees>PharmD</degrees><degrees>BCPS</degrees><xref rid="soi230009aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marable</surname><given-names initials="J">Jarrod</given-names></name><degrees>BS</degrees><xref rid="soi230009aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bethi</surname><given-names initials="S">Shipra</given-names></name><degrees>BS</degrees><xref rid="soi230009aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fleming</surname><given-names initials="J">James</given-names></name><degrees>PharmD</degrees><xref rid="soi230009aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baliga</surname><given-names initials="P">Prabhakar</given-names></name><degrees>MD</degrees><xref rid="soi230009aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>DuBay</surname><given-names initials="D">Derek</given-names></name><degrees>MD</degrees><xref rid="soi230009aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Taber</surname><given-names initials="D">David</given-names></name><degrees>PharmD</degrees><degrees>MS</degrees><degrees>BCPS</degrees><xref rid="soi230009aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rohan</surname><given-names initials="V">Vinayak</given-names></name><degrees>MD</degrees><xref rid="soi230009aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="soi230009aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="soi230009aff1"><label>1</label>Department of Pharmacy, Medical University of South Carolina, Charleston</aff><aff id="soi230009aff2"><label>2</label>College of Medicine, Medical University of South Carolina, Charleston</aff><aff id="soi230009aff3"><label>3</label>Division of Transplant Surgery, Department of Surgery, Medical University of South Carolina, Charleston</aff><aff id="soi230009aff4"><label>4</label>Division of Organ Transplantation, Department of Surgery, Northwestern University, Chicago, Illinois</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> November 20, 2022.</p><p content-type="published-online"><bold>Published Online:</bold> April 5, 2023. doi:<uri content-type="doi">10.1001/jamasurg.2023.0276</uri></p><corresp id="soi230009cor1"><bold>Corresponding Author:</bold> Taylor Carcella, PharmD, Department of Pharmacy, Medical University of South Carolina, 150 Ashley Ave, Charleston, SC 29425 (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="carcella@musc.edu">carcella@musc.edu</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Carcella had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic toggle="yes">Concept and design:</italic> Carcella, Patel, Fleming, Baliga, DuBay, Taber, Rohan.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> Carcella, Patel, Marable, Bethi, Fleming, Taber, Rohan.</p><p><italic toggle="yes">Drafting of the manuscript:</italic> Carcella, Marable, Bethi, Fleming.</p><p><italic toggle="yes">Critical revision of the manuscript for important intellectual content:</italic> Carcella, Patel, Fleming, Baliga, DuBay, Taber, Rohan.</p><p><italic toggle="yes">Statistical analysis:</italic> Carcella, Marable, Taber.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Baliga, DuBay, Taber.</p><p><italic toggle="yes">Supervision:</italic> Patel, Fleming, Baliga, Taber, Rohan.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Taber reported receiving consulting fees from Veloxis Pharmaceuticals and grants from Merck, CareDx, and Takeda Pharmaceutical Company during the conduct of the study. No other disclosures were reported.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-SOI230009-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2023-04-05T10:00"><day>5</day><month>4</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2023</year></pub-date><volume>158</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">432916</issue-id><fpage>618</fpage><lpage>624</lpage><history><date date-type="received"><day>21</day><month>6</month><year>2022</year></date><date date-type="accepted"><day>20</day><month>11</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>05</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>05</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-05 00:25:28.140"><day>05</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023 American Medical Association. All Rights Reserved.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamasurg-e230276.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamasurg-e230276.pdf">jamasurg-e230276.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/archsurg/fullarticle/10.1001/jamasurg.2023.0276"/><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-soi230009-1"><title>Question</title><p>What are the long-term outcomes associated with an opioid-sparing protocol after kidney transplant?</p></sec><sec id="ab-soi230009-2"><title>Findings</title><p>In this quality improvement project that included 743 kidney graft recipients, patients in the opioid-sparing protocol group had 99% lower odds of filling more than 100 morphine milligram equivalents during the 1-year follow-up.</p></sec><sec id="ab-soi230009-3"><title>Meaning</title><p>These findings suggest that a significant reduction in opioid use after kidney transplant was associated with the implementation of a multimodal opioid-sparing pain protocol.</p></sec></abstract><abstract abstract-type="teaser" specific-use="electronic"><p>This quality improvement study evaluated the long-term outcomes associated with an opioid-sparing protocol in adult kidney graft recipients.</p></abstract><abstract><sec id="ab-soi230009-4"><title>Importance</title><p>Opioid use following kidney transplant is associated with an increased risk of graft loss and mortality. Opioid minimization strategies and protocols have shown reductions in short-term opioid use after kidney transplant.</p></sec><sec id="ab-soi230009-5"><title>Objective</title><p>To evaluate the long-term outcomes associated with an opioid minimization protocol following kidney transplant.</p></sec><sec id="ab-soi230009-6"><title>Design, Setting, and Participants</title><p>This single-center quality improvement study evaluated postoperative and long-term opioid use before and after the implementation of a multidisciplinary, multimodal pain regimen and education process in adult kidney graft recipients from August 1, 2017, through June 30, 2020. Patient data were collected from a retrospective chart review.</p></sec><sec id="ab-soi230009-7"><title>Exposures</title><p>Preprotocol and postprotocol implementation use of opioids.</p></sec><sec id="ab-soi230009-8"><title>Main Outcomes and Measures</title><p>Between November 7 and 23, 2022, opioid use before and after protocol implementation was evaluated up to 1 year after transplant using multivariable linear and logistic regression.</p></sec><sec id="ab-soi230009-9"><title>Results</title><p>A total of 743 patients were included, with 245 patients in the preprotocol group (39.2% female and 60.8% male; mean [SD] age, 52.8 [13.1 years]) vs 498 in the postprotocol group (45.4% female and 54.6% male; mean [SD] age, 52.4 [12.9 years]). The total morphine milligram equivalents (MME) in the 1-year follow-up in the preprotocol group was 1203.7 vs 581.9 in the postprotocol group. In the postprotocol group, 313 patients (62.9%) had 0 MME in the 1-year follow-up vs 7 (2.9%) in the preprotocol group (odds ratio [OR], 57.52; 95% CI, 26.55-124.65). Patients in the postprotocol group had 99% lower odds of filling more than 100 MME in the 1-year follow-up (adjusted OR, 0.01; 95% CI, 0.01-0.02; <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). Opioid-naive patients postprotocol were one-half as likely to become long-term opioid users vs preprotocol (OR, 0.44; 95% CI, 0.20-0.98; <italic toggle="yes">P</italic>&#8201;=&#8201;.04).</p></sec><sec id="ab-soi230009-10"><title>Conclusions and Relevance</title><p>The study&#8217;s findings show a significant reduction in opioid use in kidney graft recipients associated with the implementation of a multimodal opioid-sparing pain protocol.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>